AstraZeneca shares fell 7.3% after reports said the company had preliminary negotiations with Bristol-Myers Squibb over a possible merger.

Zhitongcaijing · 4d ago
AstraZeneca shares fell 7.3% after reports said the company had preliminary negotiations with Bristol-Myers Squibb over a possible merger.